A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2018
At a glance
- Drugs Bexarotene (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 29 Jun 2018 Status changed from not yet recruiting to recruiting.
- 02 May 2018 Planned initiation date changed from 1 Jan 2018 to 1 Jun 2018.